Literature DB >> 10376964

Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.

S H Kang1, Y J Bang, H S Jong, J Y Seo, N K Kim, S J Kim.   

Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional polypeptide that inhibits cellular proliferation in most epithelial cells. cdk4 and several cyclin-dependent kinase (cdk) inhibitors (p15INK4B, p21WAF1/Cip1 and p27Kip1) have been implicated in the TGF-beta-induced cell cycle arrest. More recently, down-regulation of Cdc25A, a cdk activator, was additionally suggested as a mechanism underlying growth inhibition by TGF-beta. The existence of diverse cellular mediators of TGF-beta, however, raises the question of whether their involvement might occur in a redundant manner or coordinately in a certain cell type. Using two TGF-beta-sensitive gastric carcinoma cell lines (SNU-16 and -620), we addressed the contributory roles of several cdk inhibitors, and of cdk4 and Cdc25A, in TGF-beta-induced cell cycle arrest by comparing their temporal expression pattern in response to TGF-beta. Among the cdk inhibitors examined, p21 mRNA was most rapidly (in less than 1 h) and prominently induced by TGF-beta. In contrast, p15 mRNA was more slowly induced than p21 in SNU-620 cells, and not expressed in SNU-16 cells harbouring homozygous deletion of p15. Western blotting results confirmed the rapid increase of p21, while opposite patterns of p27 expression were observed in the two cell lines. The down-regulation of Cdc25A mRNA occurred, but was more delayed than that of p15 or p21. Until G1 arrest was established, changes in the protein levels of both Cdc25A and cdk4 were marginal. Co-immunoprecipitation with anti-cdk4 antibody showed that induced p21 associates with cdk4 and that its kinase activity is reduced by TGF-beta, which kinetically correlates closely with G1 arrest following TGF-beta treatment of both cell lines. These results suggest that in certain human epithelial cells, p21 may play an early role in TGF-beta-induced cell cycle arrest, and its cooperation with other cdk inhibitors is different depending on cell type. Delayed down-regulation of Cdc25A and cdk4 may contribute to cell adaptation to the quiescent state in the two gastric carcinoma cell lines studied.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376964      PMCID: PMC2362369          DOI: 10.1038/sj.bjc.6690478

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

Review 1.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.

Authors:  J H Kim; T Takahashi; I Chiba; J G Park; M J Birrer; J K Roh; H De Lee; J P Kim; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

4.  Cell cycle. Dams and sluices.

Authors:  K Nasmyth; T Hunt
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

5.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

6.  TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Authors:  M E Ewen; H K Sluss; L L Whitehouse; D M Livingston
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

7.  Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.

Authors:  Y Geng; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.

Authors:  Y Y Lee; S H Kang; J Y Seo; C W Jung; K U Lee; K J Choe; B K Kim; N K Kim; H P Koeffler; Y J Bang
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

9.  Mechanism of activation of the TGF-beta receptor.

Authors:  J L Wrana; L Attisano; R Wieser; F Ventura; J Massagué
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

Review 10.  Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression.

Authors:  J Filmus; R S Kerbel
Journal:  Curr Opin Oncol       Date:  1993-01       Impact factor: 3.645

View more
  5 in total

1.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

2.  Dysregulation of the TGF-beta postreceptor signaling pathway in cell lines derived from primary or metastatic ovarian cancer.

Authors:  Ling Xi; Wei Hu; Li Meng; Jianfeng Zhou; Yunping Lu; Changyu Wang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.

Authors:  K Nishioka; Y Doki; H Shiozaki; H Yamamoto; S Tamura; T Yasuda; Y Fujiwara; M Yano; H Miyata; K Kishi; H Nakagawa; A Shamma; M Monden
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

4.  Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer.

Authors:  Weiyuan Wei; Xianwei Mo; Linhai Yan; Mingwei Huang; Yang Yang; Qinwen Jin; Huage Zhong; Wenlong Cao; Kun Wu; Liucheng Wu; Zhao Li; Tingan Wang; Yuzhou Qin; Jiansi Chen
Journal:  Cancer Manag Res       Date:  2020-01-06       Impact factor: 3.989

Review 5.  Targeting TGFβ signal transduction for cancer therapy.

Authors:  Sijia Liu; Jiang Ren; Peter Ten Dijke
Journal:  Signal Transduct Target Ther       Date:  2021-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.